{"uri": "eng-9706315", "concepts": [{"uri": "http://en.wikipedia.org/wiki/AstraZeneca", "type": "org", "score": 100, "label": {"eng": "AstraZeneca"}}, {"uri": "http://en.wikipedia.org/wiki/India", "type": "loc", "score": 85, "label": {"eng": "India"}, "location": {"type": "country", "label": {"eng": "India"}}}, {"uri": "http://en.wikipedia.org/wiki/Chennai", "type": "loc", "score": 78, "label": {"eng": "Chennai"}, "location": {"type": "place", "label": {"eng": "Chennai"}, "country": {"type": "country", "label": {"eng": "India"}}}}, {"uri": "http://en.wikipedia.org/wiki/Gulf_Cooperation_Council", "type": "org", "score": 67, "label": {"eng": "Gulf Cooperation Council"}}, {"uri": "http://en.wikipedia.org/wiki/Indian_rupee", "type": "wiki", "score": 60, "label": {"eng": "Indian rupee"}}, {"uri": "http://en.wikipedia.org/wiki/Tamil_Nadu", "type": "loc", "score": 58, "label": {"eng": "Tamil Nadu"}, "location": {"type": "place", "label": {"eng": "Tamil Nadu"}, "country": {"type": "country", "label": {"eng": "India"}}}}, {"uri": "http://en.wikipedia.org/wiki/Health_care", "type": "wiki", "score": 55, "label": {"eng": "Health care"}}, {"uri": "http://en.wikipedia.org/wiki/Crore", "type": "wiki", "score": 54, "label": {"eng": "Crore"}}, {"uri": "http://en.wikipedia.org/wiki/Privately_held_company", "type": "wiki", "score": 46, "label": {"eng": "Privately held company"}}, {"uri": "http://en.wikipedia.org/wiki/United_Kingdom", "type": "loc", "score": 46, "label": {"eng": "United Kingdom"}, "location": {"type": "country", "label": {"eng": "United Kingdom"}}}, {"uri": "http://en.wikipedia.org/wiki/Order_of_St_Michael_and_St_George", "type": "wiki", "score": 38, "label": {"eng": "Order of St Michael and St George"}}, {"uri": "http://en.wikipedia.org/wiki/Asia", "type": "loc", "score": 38, "label": {"eng": "Asia"}, "location": null}, {"uri": "http://en.wikipedia.org/wiki/Supply_chain", "type": "wiki", "score": 35, "label": {"eng": "Supply chain"}}, {"uri": "http://en.wikipedia.org/wiki/Machine_learning", "type": "wiki", "score": 35, "label": {"eng": "Machine learning"}}, {"uri": "http://en.wikipedia.org/wiki/Artificial_intelligence", "type": "wiki", "score": 35, "label": {"eng": "Artificial intelligence"}}, {"uri": "http://en.wikipedia.org/wiki/Pharmaceutical_industry", "type": "wiki", "score": 30, "label": {"eng": "Pharmaceutical industry"}}, {"uri": "http://en.wikipedia.org/wiki/Vice_President_of_the_United_States", "type": "wiki", "score": 29, "label": {"eng": "Vice President of the United States"}}, {"uri": "http://en.wikipedia.org/wiki/Chief_executive_officer", "type": "wiki", "score": 26, "label": {"eng": "Chief executive officer"}}, {"uri": "http://en.wikipedia.org/wiki/Data_science", "type": "wiki", "score": 25, "label": {"eng": "Data science"}}, {"uri": "http://en.wikipedia.org/wiki/Chief_minister", "type": "wiki", "score": 21, "label": {"eng": "Chief minister"}}, {"uri": "http://en.wikipedia.org/wiki/M._K._Stalin", "type": "person", "score": 21, "label": {"eng": "M. K. Stalin"}}, {"uri": "http://en.wikipedia.org/wiki/Information_technology", "type": "wiki", "score": 21, "label": {"eng": "Information technology"}}, {"uri": "http://en.wikipedia.org/wiki/Ecosystem", "type": "wiki", "score": 20, "label": {"eng": "Ecosystem"}}, {"uri": "http://en.wikipedia.org/wiki/Analytics", "type": "wiki", "score": 16, "label": {"eng": "Analytics"}}, {"uri": "http://en.wikipedia.org/wiki/Productivity", "type": "wiki", "score": 16, "label": {"eng": "Productivity"}}, {"uri": "http://en.wikipedia.org/wiki/Economic_development", "type": "wiki", "score": 16, "label": {"eng": "Economic development"}}, {"uri": "http://en.wikipedia.org/wiki/Srinivasa_Ramanujan", "type": "person", "score": 12, "label": {"eng": "Srinivasa Ramanujan"}}], "eventDate": "2024-07-04", "totalArticleCount": 11, "title": {"eng": "AstraZeneca to invest Rs 250 crore on expansion of its GCC in India"}, "summary": {"eng": "AstraZeneca India Private Limited (AZIPL), the global capability centre (GCC) of British-Swedish drugmaker AstraZeneca, announced an investment of Rs 250 crore ($30 million) to expand its Global Innovation and Technology Centre (GITC) in Chennai.\n\nThe expansion includes adding close to 1,300 job roles focused on driving innovation, enhancing efficiency, and streamlining operations across the company globally.\n\nThe facility currently occupies 334,000 square feet of office space at Ramanujan IT Cit"}, "location": {"type": "place", "label": {"eng": "Chennai"}, "country": {"type": "country", "label": {"eng": "India"}}}, "categories": [{"uri": "dmoz/Business", "label": "dmoz/Business", "wgt": 100}, {"uri": "dmoz/Business/Biotechnology_and_Pharmaceuticals", "label": "dmoz/Business/Biotechnology and Pharmaceuticals", "wgt": 87}, {"uri": "dmoz/Business/Biotechnology_and_Pharmaceuticals/Consulting", "label": "dmoz/Business/Biotechnology and Pharmaceuticals/Consulting", "wgt": 100}, {"uri": "news/Business", "label": "news/Business", "wgt": 84}], "articleCounts": {"eng": 11}, "sentiment": 0.4901960784313726, "breakingScore": 0.2614899251047074}
{"uri": "8209251380", "lang": "eng", "isDuplicate": false, "date": "2024-07-04", "time": "09:31:41", "dateTime": "2024-07-04T09:31:41Z", "dateTimePub": "2024-07-04T09:31:25Z", "dataType": "news", "sim": 0.9607843160629272, "url": "https://www.thehansindia.com/business/astrazeneca-to-expand-its-chennai-gcc-at-rs-250-crore-outlay-889330", "title": "AstraZeneca to expand its Chennai GCC at Rs 250 crore outlay", "body": "Chennai: AstraZeneca India Private Limited (AZIPL), the Global Capability Centre (GCC) of the pharma group AstraZeneca on Thursday said it will invest Rs 250 crore on expanding its Global Innovation and Technology Centre (GITC) here.\n\nThe expansion includes close to 1,300 roles focused on driving innovation, enhancing efficiency, and streamlining operations across the company globally.\n\nThe expanded facility was inaugurated in a ceremony officiated by the Minister of Industries Tamil Nadu, T.R.B. Rajaa, British Deputy High Commissioner to India Christina Scott CMG, AstraZeneca Vice President for Asia Area Sylvia Varela and others.\n\nThe investment marks a significant milestone in AstraZeneca's growth story in India as it celebrates its 45th year in the country this month.\n\nWith the highly skilled roles to be brought in by 2025, the expanded GITC will propel the company's vision to leverage technologies such as enterprise platforms, artificial intelligence, machine learning, data science, and supply chain analytics to shape healthcare outcomes.\n\n\"Technology is the driving force behind innovation and we are committed to make Tamil Nadu an epicentre of technology and research. This collaboration with AstraZeneca aligns perfectly with our vision to foster innovation and create high-value opportunities for the people of Tamil Nadu. We are committed to ensure Tamil Nadu's position as a premier investment destination for companies around the world,\" Tamil Nadu Chief Minister M.K.Stalin said.\n\nMinister of Industries Tamil Nadu T.R.B Rajaa said that in the last three years, Chennai has rapidly emerged as the GCC Capital of India, leading to historical levels of office space absorption and bringing high-quality jobs to the state.\n\nReferring to AstraZeneca's GCC, Rajaa said, the investment will not only enhance our state's capabilities in the pharmaceutical and healthcare sectors but also spur technological advancements and economic development.\n\n\"Our expansion in Chennai signifies AstraZeneca's unwavering commitment to pioneering science and innovation. India's rich talent pool and dynamic ecosystem for digital advancements make it a pivotal hub for our global operations,\" Dr. Sanjeev Panchal, Managing Director & Country President AstraZeneca Pharma India Limited (AZPIL).\n\nSince its inception, the GITC in Chennai has evolved from providing traditional IT services to becoming an engine of AstraZeneca's digital journey, driving productivity, simplification, technology delivery, and innovation across the company's global operations, supporting the delivery of life-changing medicines to patients worldwide.\n\nThe facility currently occupies 334,000 square feet of office space at Ramanujan IT City, with plans to add approximately 180,000 square feet over the next six months to accommodate this expansion, creating AstraZeneca's biggest global capability centre.", "source": {"uri": "thehansindia.com", "dataType": "news", "title": "The Hans India"}, "authors": [{"uri": "hans_india@thehansindia.com", "name": "Hans India", "type": "author", "isAgency": false}], "concepts": [{"uri": "http://en.wikipedia.org/wiki/AstraZeneca", "type": "org", "score": 5, "label": {"eng": "AstraZeneca"}}, {"uri": "http://en.wikipedia.org/wiki/Tamil_Nadu", "type": "loc", "score": 5, "label": {"eng": "Tamil Nadu"}, "location": {"type": "place", "label": {"eng": "Tamil Nadu"}, "country": {"type": "country", "label": {"eng": "India"}}}}, {"uri": "http://en.wikipedia.org/wiki/India", "type": "loc", "score": 5, "label": {"eng": "India"}, "location": {"type": "country", "label": {"eng": "India"}}}, {"uri": "http://en.wikipedia.org/wiki/Gulf_Cooperation_Council", "type": "org", "score": 4, "label": {"eng": "Gulf Cooperation Council"}}, {"uri": "http://en.wikipedia.org/wiki/Chennai", "type": "loc", "score": 4, "label": {"eng": "Chennai"}, "location": {"type": "place", "label": {"eng": "Chennai"}, "country": {"type": "country", "label": {"eng": "India"}}}}, {"uri": "http://en.wikipedia.org/wiki/Order_of_St_Michael_and_St_George", "type": "wiki", "score": 3, "label": {"eng": "Order of St Michael and St George"}}, {"uri": "http://en.wikipedia.org/wiki/Privately_held_company", "type": "wiki", "score": 3, "label": {"eng": "Privately held company"}}, {"uri": "http://en.wikipedia.org/wiki/Indian_rupee", "type": "wiki", "score": 3, "label": {"eng": "Indian rupee"}}, {"uri": "http://en.wikipedia.org/wiki/Crore", "type": "wiki", "score": 3, "label": {"eng": "Crore"}}, {"uri": "http://en.wikipedia.org/wiki/Vice_President_of_the_United_States", "type": "wiki", "score": 3, "label": {"eng": "Vice President of the United States"}}, {"uri": "http://en.wikipedia.org/wiki/Health_care", "type": "wiki", "score": 3, "label": {"eng": "Health care"}}, {"uri": "http://en.wikipedia.org/wiki/Asia", "type": "loc", "score": 3, "label": {"eng": "Asia"}, "location": null}, {"uri": "http://en.wikipedia.org/wiki/United_Kingdom", "type": "loc", "score": 3, "label": {"eng": "United Kingdom"}, "location": {"type": "country", "label": {"eng": "United Kingdom"}}}, {"uri": "http://en.wikipedia.org/wiki/Chief_minister", "type": "wiki", "score": 2, "label": {"eng": "Chief minister"}}, {"uri": "http://en.wikipedia.org/wiki/M._K._Stalin", "type": "person", "score": 2, "label": {"eng": "M. K. Stalin"}}, {"uri": "http://en.wikipedia.org/wiki/Supply_chain", "type": "wiki", "score": 2, "label": {"eng": "Supply chain"}}, {"uri": "http://en.wikipedia.org/wiki/Machine_learning", "type": "wiki", "score": 2, "label": {"eng": "Machine learning"}}, {"uri": "http://en.wikipedia.org/wiki/Data_science", "type": "wiki", "score": 2, "label": {"eng": "Data science"}}, {"uri": "http://en.wikipedia.org/wiki/Artificial_intelligence", "type": "wiki", "score": 2, "label": {"eng": "Artificial intelligence"}}, {"uri": "http://en.wikipedia.org/wiki/Srinivasa_Ramanujan", "type": "person", "score": 1, "label": {"eng": "Srinivasa Ramanujan"}}, {"uri": "http://en.wikipedia.org/wiki/Productivity", "type": "wiki", "score": 1, "label": {"eng": "Productivity"}}, {"uri": "http://en.wikipedia.org/wiki/Information_technology", "type": "wiki", "score": 1, "label": {"eng": "Information technology"}}, {"uri": "http://en.wikipedia.org/wiki/Ecosystem", "type": "wiki", "score": 1, "label": {"eng": "Ecosystem"}}, {"uri": "http://en.wikipedia.org/wiki/Economic_development", "type": "wiki", "score": 1, "label": {"eng": "Economic development"}}, {"uri": "http://en.wikipedia.org/wiki/Pharmaceutical_industry", "type": "wiki", "score": 1, "label": {"eng": "Pharmaceutical industry"}}, {"uri": "http://en.wikipedia.org/wiki/Chief_executive_officer", "type": "wiki", "score": 1, "label": {"eng": "Chief executive officer"}}], "categories": [{"uri": "dmoz/Business", "label": "dmoz/Business", "wgt": 100}, {"uri": "dmoz/Business/Biotechnology_and_Pharmaceuticals", "label": "dmoz/Business/Biotechnology and Pharmaceuticals", "wgt": 100}, {"uri": "dmoz/Business/Biotechnology_and_Pharmaceuticals/Consulting", "label": "dmoz/Business/Biotechnology and Pharmaceuticals/Consulting", "wgt": 100}, {"uri": "news/Business", "label": "news/Business", "wgt": 88}], "image": "https://assets.thehansindia.com/h-upload/2024/07/04/1459484-astrazeneca.jpg", "originalArticle": null, "storyUri": "eng-9706315", "eventUri": "eng-9706315", "location": {"type": "place", "label": {"eng": "Chennai"}, "country": {"type": "country", "label": {"eng": "India"}}}, "extractedDates": null, "sentiment": 0.4901960784313726, "wgt": 245, "relevance": 1}
{"uri": "8209321978", "lang": "eng", "isDuplicate": false, "date": "2024-07-04", "time": "10:14:26", "dateTime": "2024-07-04T10:14:26Z", "dateTimePub": "2024-07-04T10:14:09Z", "dataType": "news", "sim": 0.9254902005195618, "url": "https://www.biospectrumindia.com/news/16/24867/astrazeneca-to-invest-rs-250-crore-in-indias-global-innovation-and-technology-centre-adding-1300-skilled-jobs-by-2025-.html", "title": "AstraZeneca to invest Rs 250 crore in India's tech centre, adding 1,300 jobs by 2025.", "body": "The investment marks a significant milestone in AstraZeneca's growth story in India as it celebrates its 45th year in the country this month.\n\nAstraZeneca India Private Limited (AZIPL), the Global Capability Centre (GCC) of AstraZeneca, announced an investment of 250 crore rupees ($30 million) to expand its Global Innovation and Technology Centre (GITC) in Chennai, Tamil Nadu, which includes close to 1,300 roles focused on driving innovation, enhancing efficiency, and streamlining operations across the company globally.\n\nThe expanded facility was inaugurated today in a ceremony officiated by the Honourable Minister of Industries Tamil Nadu, Dr. T.R.B. Rajaa, British Deputy High Commissioner to India, Ms. Christina Scott CMG, AstraZeneca Vice President for Asia Area Ms Sylvia Varela, as well as AstraZeneca's leadership team in the country.\n\nThe investment marks a significant milestone in AstraZeneca's growth story in India as it celebrates its 45 year in the country this month. With the highly skilled roles to be brought in by 2025, the expanded GITC will propel company's vision to leverage technologies such as enterprise platforms, artificial intelligence, machine learning, data science, and supply chain analytics to shape healthcare outcomes.\n\nDr. Sanjeev Panchal, Managing Director & Country President AstraZeneca Pharma India Limited (AZPIL), said, \"Our expansion in Chennai signifies AstraZeneca's unwavering commitment to pioneering science and innovation. India's rich talent pool and dynamic ecosystem for digital advancements make it a pivotal hub for our global operations. This strategic investment underscores our dedication to improving patient outcomes through cutting-edge technology and reinforces our aspiration to transform the future of the healthcare industry. I am immensely proud of our team's achievements and excited for the future as we continue to harness science to bring life-changing medicines to patients worldwide.\"\n\nThiru. MK Stalin, Chief Minister of Tamil Nadu said, \"Technology is the driving force behind innovation and we are committed to make Tamil Nadu an epicentre of technology and research. This collaboration with AstraZeneca aligns perfectly with our vision to foster innovation and create high-value opportunities for the people of Tamil Nadu. We are committed to ensure Tamil Nadu's position as a premier investment destination for companies around the world.\"\n\nDr. T.R.B. Rajaa, Industries Minister, Tamil Nadu said, \"AstraZeneca's decision to further expand their facility in Chennai is a reinforcement of their faith and commitment to Tamil Nadu's unmatched talent pool and business ecosystem. In the last three years, under the leadership of our Honourable Chief Minister of Tamil Nadu Thiru. MK Stalin Avargal, Chennai has rapidly emerged as the GCC Capital of India, leading to historical levels of office space absorption and bringing high-quality jobs to the state. We are delighted that AstraZeneca is part of this exciting growth journey, and we congratulate team AstraZeneca on this expansion. This investment will not only enhance our state's capabilities in the pharmaceutical and healthcare sectors but also spur technological advancements and economic development. With this expansion and talent exposure, AstraZeneca is contributing to our vision of making Tamil Nadu a global hub for innovation-driven industries.\"\n\nSince its inception, the GITC in Chennai has evolved from providing traditional IT services to becoming an engine of AstraZeneca's digital journey, driving productivity, simplification, technology delivery, and innovation across the company's global operations, supporting the delivery of life-changing medicines to patients worldwide. The facility currently occupies 334,000 square feet of office space at Ramanujan IT City, with plans to add approximately 180,000 square feet over the next six months to accommodate this expansion, creating AstraZeneca's biggest global capability centre.", "source": {"uri": "biospectrumindia.com", "dataType": "news", "title": "biospectrumindia.com"}, "authors": [], "concepts": [{"uri": "http://en.wikipedia.org/wiki/AstraZeneca", "type": "org", "score": 5, "label": {"eng": "AstraZeneca"}}, {"uri": "http://en.wikipedia.org/wiki/Chennai", "type": "loc", "score": 5, "label": {"eng": "Chennai"}, "location": {"type": "place", "label": {"eng": "Chennai"}, "country": {"type": "country", "label": {"eng": "India"}}}}, {"uri": "http://en.wikipedia.org/wiki/Tamil_Nadu", "type": "loc", "score": 5, "label": {"eng": "Tamil Nadu"}, "location": {"type": "place", "label": {"eng": "Tamil Nadu"}, "country": {"type": "country", "label": {"eng": "India"}}}}, {"uri": "http://en.wikipedia.org/wiki/India", "type": "loc", "score": 5, "label": {"eng": "India"}, "location": {"type": "country", "label": {"eng": "India"}}}, {"uri": "http://en.wikipedia.org/wiki/High_commissioner", "type": "wiki", "score": 3, "label": {"eng": "High commissioner"}}, {"uri": "http://en.wikipedia.org/wiki/Gulf_Cooperation_Council", "type": "org", "score": 3, "label": {"eng": "Gulf Cooperation Council"}}, {"uri": "http://en.wikipedia.org/wiki/Order_of_St_Michael_and_St_George", "type": "wiki", "score": 3, "label": {"eng": "Order of St Michael and St George"}}, {"uri": "http://en.wikipedia.org/wiki/The_Honourable", "type": "wiki", "score": 3, "label": {"eng": "The Honourable"}}, {"uri": "http://en.wikipedia.org/wiki/Privately_held_company", "type": "wiki", "score": 3, "label": {"eng": "Privately held company"}}, {"uri": "http://en.wikipedia.org/wiki/Indian_rupee", "type": "wiki", "score": 3, "label": {"eng": "Indian rupee"}}, {"uri": "http://en.wikipedia.org/wiki/Crore", "type": "wiki", "score": 3, "label": {"eng": "Crore"}}, {"uri": "http://en.wikipedia.org/wiki/Vice_President_of_the_United_States", "type": "wiki", "score": 3, "label": {"eng": "Vice President of the United States"}}, {"uri": "http://en.wikipedia.org/wiki/Health_care", "type": "wiki", "score": 3, "label": {"eng": "Health care"}}, {"uri": "http://en.wikipedia.org/wiki/Asia", "type": "loc", "score": 3, "label": {"eng": "Asia"}, "location": null}, {"uri": "http://en.wikipedia.org/wiki/United_Kingdom", "type": "loc", "score": 3, "label": {"eng": "United Kingdom"}, "location": {"type": "country", "label": {"eng": "United Kingdom"}}}, {"uri": "http://en.wikipedia.org/wiki/Chief_minister", "type": "wiki", "score": 2, "label": {"eng": "Chief minister"}}, {"uri": "http://en.wikipedia.org/wiki/M._K._Stalin", "type": "person", "score": 2, "label": {"eng": "M. K. Stalin"}}, {"uri": "http://en.wikipedia.org/wiki/Supply_chain", "type": "wiki", "score": 2, "label": {"eng": "Supply chain"}}, {"uri": "http://en.wikipedia.org/wiki/Machine_learning", "type": "wiki", "score": 2, "label": {"eng": "Machine learning"}}, {"uri": "http://en.wikipedia.org/wiki/Ecosystem", "type": "wiki", "score": 2, "label": {"eng": "Ecosystem"}}, {"uri": "http://en.wikipedia.org/wiki/Artificial_intelligence", "type": "wiki", "score": 2, "label": {"eng": "Artificial intelligence"}}, {"uri": "http://en.wikipedia.org/wiki/Chief_executive_officer", "type": "wiki", "score": 2, "label": {"eng": "Chief executive officer"}}, {"uri": "http://en.wikipedia.org/wiki/Srinivasa_Ramanujan", "type": "person", "score": 1, "label": {"eng": "Srinivasa Ramanujan"}}, {"uri": "http://en.wikipedia.org/wiki/Global_city", "type": "wiki", "score": 1, "label": {"eng": "Global city"}}, {"uri": "http://en.wikipedia.org/wiki/Productivity", "type": "wiki", "score": 1, "label": {"eng": "Productivity"}}, {"uri": "http://en.wikipedia.org/wiki/Information_technology", "type": "wiki", "score": 1, "label": {"eng": "Information technology"}}, {"uri": "http://en.wikipedia.org/wiki/Economic_development", "type": "wiki", "score": 1, "label": {"eng": "Economic development"}}, {"uri": "http://en.wikipedia.org/wiki/Pharmaceutical_industry", "type": "wiki", "score": 1, "label": {"eng": "Pharmaceutical industry"}}], "categories": [{"uri": "dmoz/Business/Biotechnology_and_Pharmaceuticals", "label": "dmoz/Business/Biotechnology and Pharmaceuticals", "wgt": 100}, {"uri": "dmoz/Society/Religion_and_Spirituality/Sikhism", "label": "dmoz/Society/Religion and Spirituality/Sikhism", "wgt": 100}, {"uri": "dmoz/Business/Biotechnology_and_Pharmaceuticals/Consulting", "label": "dmoz/Business/Biotechnology and Pharmaceuticals/Consulting", "wgt": 100}, {"uri": "news/Business", "label": "news/Business", "wgt": 93}], "image": null, "originalArticle": null, "storyUri": "eng-9706315", "eventUri": "eng-9706315", "location": null, "extractedDates": null, "sentiment": 0.5921568627450979, "wgt": 236, "relevance": 1}
{"uri": "2024-07-411196592", "lang": "eng", "isDuplicate": false, "date": "2024-07-04", "time": "11:53:59", "dateTime": "2024-07-04T11:53:59Z", "dateTimePub": "2024-07-04T11:38:05Z", "dataType": "news", "sim": 0.9254902005195618, "url": "https://www.zeebiz.com/companies/news-astrazeneca-azipl-expand-chennai-global-capability-centre-pharma-global-innovation-and-technology-centre-tamil-nadu-ramanujan-it-city-299867", "title": "AstraZeneca to expand its Chennai GCC at Rs 250 crore outlay", "body": "Referring to AstraZeneca's GCC, Rajaa said, the investment will not only enhance our state's capabilities in the pharmaceutical and healthcare sectors but also spur technological advancements and economic development. Image: ANI\n\nAstraZeneca India Private Limited (AZIPL), the Global Capability Centre (GCC) of the pharma group AstraZeneca on Thursday said it will invest Rs 250 crore on expanding its Global Innovation and Technology Centre (GITC) here.\n\nThe expansion includes close to 1,300 roles focused on driving innovation, enhancing efficiency, and streamlining operations across the company globally.\n\nThe expanded facility was inaugurated in a ceremony officiated by the Minister of Industries Tamil Nadu, T.R.B. Rajaa, British Deputy High Commissioner to India Christina Scott CMG, AstraZeneca Vice President for Asia Area Sylvia Varela and others.\n\nThe investment marks a significant milestone in AstraZeneca's growth story in India as it celebrates its 45th year in the country this month.\n\nWith the highly skilled roles to be brought in by 2025, the expanded GITC will propel the company's vision to leverage technologies such as enterprise platforms, artificial intelligence, machine learning, data science, and supply chain analytics to shape healthcare outcomes.\n\n\"Technology is the driving force behind innovation and we are committed to make Tamil Nadu an epicentre of technology and research. This collaboration with AstraZeneca aligns perfectly with our vision to foster innovation and create high-value opportunities for the people of Tamil Nadu. We are committed to ensure Tamil Nadu's position as a premier investment destination for companies around the world,\" Tamil Nadu Chief Minister M.K.Stalin said.\n\nMinister of Industries Tamil Nadu T.R.B Rajaa said that in the last three years, Chennai has rapidly emerged as the GCC Capital of India, leading to historical levels of office space absorption and bringing high-quality jobs to the state.\n\nReferring to AstraZeneca's GCC, Rajaa said, the investment will not only enhance our state's capabilities in the pharmaceutical and healthcare sectors but also spur technological advancements and economic development.\n\n\"Our expansion in Chennai signifies AstraZeneca's unwavering commitment to pioneering science and innovation. India's rich talent pool and dynamic ecosystem for digital advancements make it a pivotal hub for our global operations,\" Dr. Sanjeev Panchal, Managing Director & Country President AstraZeneca Pharma India Limited (AZPIL).\n\nSince its inception, the GITC in Chennai has evolved from providing traditional IT services to becoming an engine of AstraZeneca's digital journey, driving productivity, simplification, technology delivery, and innovation across the company's global operations, supporting the delivery of life-changing medicines to patients worldwide.\n\nThe facility currently occupies 334,000 square feet of office space at Ramanujan IT City, with plans to add approximately 180,000 square feet over the next six months to accommodate this expansion, creating AstraZeneca's biggest global capability centre.", "source": {"uri": "zeebiz.com", "dataType": "news", "title": "Zee Business"}, "authors": [], "concepts": [{"uri": "http://en.wikipedia.org/wiki/Gulf_Cooperation_Council", "type": "org", "score": 5, "label": {"eng": "Gulf Cooperation Council"}}, {"uri": "http://en.wikipedia.org/wiki/AstraZeneca", "type": "org", "score": 5, "label": {"eng": "AstraZeneca"}}, {"uri": "http://en.wikipedia.org/wiki/Indian_rupee", "type": "wiki", "score": 5, "label": {"eng": "Indian rupee"}}, {"uri": "http://en.wikipedia.org/wiki/Crore", "type": "wiki", "score": 5, "label": {"eng": "Crore"}}, {"uri": "http://en.wikipedia.org/wiki/Tamil_Nadu", "type": "loc", "score": 5, "label": {"eng": "Tamil Nadu"}, "location": {"type": "place", "label": {"eng": "Tamil Nadu"}, "country": {"type": "country", "label": {"eng": "India"}}}}, {"uri": "http://en.wikipedia.org/wiki/India", "type": "loc", "score": 5, "label": {"eng": "India"}, "location": {"type": "country", "label": {"eng": "India"}}}, {"uri": "http://en.wikipedia.org/wiki/Health_care", "type": "wiki", "score": 4, "label": {"eng": "Health care"}}, {"uri": "http://en.wikipedia.org/wiki/Chennai", "type": "loc", "score": 4, "label": {"eng": "Chennai"}, "location": {"type": "place", "label": {"eng": "Chennai"}, "country": {"type": "country", "label": {"eng": "India"}}}}, {"uri": "http://en.wikipedia.org/wiki/Asian_News_International", "type": "org", "score": 3, "label": {"eng": "Asian News International"}}, {"uri": "http://en.wikipedia.org/wiki/Privately_held_company", "type": "wiki", "score": 3, "label": {"eng": "Privately held company"}}, {"uri": "http://en.wikipedia.org/wiki/Economic_development", "type": "wiki", "score": 3, "label": {"eng": "Economic development"}}, {"uri": "http://en.wikipedia.org/wiki/Pharmaceutical_industry", "type": "wiki", "score": 3, "label": {"eng": "Pharmaceutical industry"}}, {"uri": "http://en.wikipedia.org/wiki/United_Kingdom", "type": "loc", "score": 3, "label": {"eng": "United Kingdom"}, "location": {"type": "country", "label": {"eng": "United Kingdom"}}}, {"uri": "http://en.wikipedia.org/wiki/Order_of_St_Michael_and_St_George", "type": "wiki", "score": 2, "label": {"eng": "Order of St Michael and St George"}}, {"uri": "http://en.wikipedia.org/wiki/Supply_chain", "type": "wiki", "score": 2, "label": {"eng": "Supply chain"}}, {"uri": "http://en.wikipedia.org/wiki/Machine_learning", "type": "wiki", "score": 2, "label": {"eng": "Machine learning"}}, {"uri": "http://en.wikipedia.org/wiki/Vice_President_of_the_United_States", "type": "wiki", "score": 2, "label": {"eng": "Vice President of the United States"}}, {"uri": "http://en.wikipedia.org/wiki/Artificial_intelligence", "type": "wiki", "score": 2, "label": {"eng": "Artificial intelligence"}}, {"uri": "http://en.wikipedia.org/wiki/Asia", "type": "loc", "score": 2, "label": {"eng": "Asia"}, "location": null}, {"uri": "http://en.wikipedia.org/wiki/Chief_minister", "type": "wiki", "score": 1, "label": {"eng": "Chief minister"}}, {"uri": "http://en.wikipedia.org/wiki/Srinivasa_Ramanujan", "type": "person", "score": 1, "label": {"eng": "Srinivasa Ramanujan"}}, {"uri": "http://en.wikipedia.org/wiki/M._K._Stalin", "type": "person", "score": 1, "label": {"eng": "M. K. Stalin"}}, {"uri": "http://en.wikipedia.org/wiki/Productivity", "type": "wiki", "score": 1, "label": {"eng": "Productivity"}}, {"uri": "http://en.wikipedia.org/wiki/Information_technology", "type": "wiki", "score": 1, "label": {"eng": "Information technology"}}, {"uri": "http://en.wikipedia.org/wiki/Ecosystem", "type": "wiki", "score": 1, "label": {"eng": "Ecosystem"}}, {"uri": "http://en.wikipedia.org/wiki/Chief_executive_officer", "type": "wiki", "score": 1, "label": {"eng": "Chief executive officer"}}], "categories": [{"uri": "dmoz/Business/Biotechnology_and_Pharmaceuticals", "label": "dmoz/Business/Biotechnology and Pharmaceuticals", "wgt": 12}, {"uri": "dmoz/Business/Financial_Services/Venture_Capital", "label": "dmoz/Business/Financial Services/Venture Capital", "wgt": 13}, {"uri": "dmoz/Business/Investing/Guides", "label": "dmoz/Business/Investing/Guides", "wgt": 13}, {"uri": "dmoz/Business/Financial_Services/Investment_Services", "label": "dmoz/Business/Financial Services/Investment Services", "wgt": 13}, {"uri": "dmoz/Society/Politics/Globalization", "label": "dmoz/Society/Politics/Globalization", "wgt": 14}, {"uri": "news/Business", "label": "news/Business", "wgt": 97}], "image": "https://cdn.zeebiz.com/sites/default/files/2024/07/04/303252-astrazeneca-ani.png", "originalArticle": null, "storyUri": "eng-9706315", "eventUri": "eng-9706315", "location": null, "extractedDates": null, "sentiment": 0.2549019607843137, "wgt": 236, "relevance": 1}
{"uri": "8209398816", "lang": "eng", "isDuplicate": false, "date": "2024-07-04", "time": "11:02:09", "dateTime": "2024-07-04T11:02:09Z", "dateTimePub": "2024-07-04T11:01:40Z", "dataType": "news", "sim": 0.9098039269447327, "url": "https://english.jagran.com/business/astrazeneca-to-expand-its-chennai-gcc-at-rs-250-crore-outlay-chennai-july4-10171355", "title": "AstraZeneca To Expand Its Chennai GCC At Rs 250 Crore Outlay Chennai, July 4", "body": "AstraZeneca India Private Limited (AZIPL), the Global Capability Centre (GCC) of the pharma group AstraZeneca on Thursday said it will invest Rs 250 crore on expanding its Global Innovation and Technology Centre (GITC) here.\n\nThe expansion includes close to 1,300 roles focused on driving innovation, enhancing efficiency, and streamlining operations across the company globally. The expanded facility was inaugurated in a ceremony officiated by the Minister of Industries Tamil Nadu, T.R.B. Rajaa, British Deputy High Commissioner to India Christina Scott CMG, AstraZeneca Vice President for Asia Area Sylvia Varela, and others. The investment marks a significant milestone in AstraZeneca's growth story in India as it celebrates its 45th year in the country this month.\n\nAlso Read: Budget: Nirmala Sitharaman To Present Full Budget For 2024-25 on July 24th: Report\n\nWith the highly skilled roles to be brought in by 2025, the expanded GITC will propel the company's vision to leverage technologies such as enterprise platforms, artificial intelligence, machine learning, data science, and supply chain analytics to shape healthcare outcomes.\"\n\nTechnology is the driving force behind innovation and we are committed to making Tamil Nadu an epicenter of technology and research. This collaboration with AstraZeneca aligns perfectly with our vision to foster innovation and create high-value opportunities for the people of Tamil Nadu. We are committed to ensuring Tamil Nadu's position as a premier investment destination for companies around the world,\" Tamil Nadu Chief Minister M.K.Stalin said.\n\nMinister of Industries Tamil Nadu T.R.B Rajaa said that in the last three years, Chennai has rapidly emerged as the GCC Capital of India, leading to historical levels of office space absorption and bringing high-quality jobs to the state.\n\nReferring to AstraZeneca's GCC, Rajaa said, the investment will not only enhance our state's capabilities in the pharmaceutical and healthcare sectors but also spur technological advancements and economic development.\"Our expansion in Chennai signifies AstraZeneca's unwavering commitment to pioneering science and innovation. India's rich talent pool and dynamic ecosystem for digital advancements make it a pivotal hub for our global operations,\"\u009d Dr Sanjeev Panchal, Managing Director & Country President AstraZeneca Pharma India Limited (AZPIL).\n\nSince its inception, the GITC in Chennai has evolved from providing traditional IT services to becoming an engine of AstraZeneca's digital journey, driving productivity, simplification, technology delivery, and innovation across the company's global operations, supporting the delivery of life-changing medicines to patients worldwide. The facility currently occupies 334,000 square feet of office space at Ramanujan IT City, with plans to add approximately 180,000 square feet over the next six months to accommodate this expansion, creating AstraZeneca's biggest global capability center.\n\nAlso Read: Housing Sales Up 11% In January-June To Hit 10-Year Peak: Knight Frank\n\nDisclaimer: This story has been directly published from the agency feed. No Changes have been made.", "source": {"uri": "english.jagran.com", "dataType": "news", "title": "Jagran English"}, "authors": [], "concepts": [{"uri": "http://en.wikipedia.org/wiki/AstraZeneca", "type": "org", "score": 5, "label": {"eng": "AstraZeneca"}}, {"uri": "http://en.wikipedia.org/wiki/Tamil_Nadu", "type": "loc", "score": 5, "label": {"eng": "Tamil Nadu"}, "location": {"type": "place", "label": {"eng": "Tamil Nadu"}, "country": {"type": "country", "label": {"eng": "India"}}}}, {"uri": "http://en.wikipedia.org/wiki/India", "type": "loc", "score": 5, "label": {"eng": "India"}, "location": {"type": "country", "label": {"eng": "India"}}}, {"uri": "http://en.wikipedia.org/wiki/Gulf_Cooperation_Council", "type": "org", "score": 4, "label": {"eng": "Gulf Cooperation Council"}}, {"uri": "http://en.wikipedia.org/wiki/Order_of_St_Michael_and_St_George", "type": "wiki", "score": 3, "label": {"eng": "Order of St Michael and St George"}}, {"uri": "http://en.wikipedia.org/wiki/Nirmala_Sitharaman", "type": "person", "score": 3, "label": {"eng": "Nirmala Sitharaman"}}, {"uri": "http://en.wikipedia.org/wiki/Privately_held_company", "type": "wiki", "score": 3, "label": {"eng": "Privately held company"}}, {"uri": "http://en.wikipedia.org/wiki/Indian_rupee", "type": "wiki", "score": 3, "label": {"eng": "Indian rupee"}}, {"uri": "http://en.wikipedia.org/wiki/Crore", "type": "wiki", "score": 3, "label": {"eng": "Crore"}}, {"uri": "http://en.wikipedia.org/wiki/Vice_President_of_the_United_States", "type": "wiki", "score": 3, "label": {"eng": "Vice President of the United States"}}, {"uri": "http://en.wikipedia.org/wiki/Health_care", "type": "wiki", "score": 3, "label": {"eng": "Health care"}}, {"uri": "http://en.wikipedia.org/wiki/Asia", "type": "loc", "score": 3, "label": {"eng": "Asia"}, "location": null}, {"uri": "http://en.wikipedia.org/wiki/United_Kingdom", "type": "loc", "score": 3, "label": {"eng": "United Kingdom"}, "location": {"type": "country", "label": {"eng": "United Kingdom"}}}, {"uri": "http://en.wikipedia.org/wiki/Chief_minister", "type": "wiki", "score": 2, "label": {"eng": "Chief minister"}}, {"uri": "http://en.wikipedia.org/wiki/M._K._Stalin", "type": "person", "score": 2, "label": {"eng": "M. K. Stalin"}}, {"uri": "http://en.wikipedia.org/wiki/Supply_chain", "type": "wiki", "score": 2, "label": {"eng": "Supply chain"}}, {"uri": "http://en.wikipedia.org/wiki/Machine_learning", "type": "wiki", "score": 2, "label": {"eng": "Machine learning"}}, {"uri": "http://en.wikipedia.org/wiki/Data_science", "type": "wiki", "score": 2, "label": {"eng": "Data science"}}, {"uri": "http://en.wikipedia.org/wiki/Artificial_intelligence", "type": "wiki", "score": 2, "label": {"eng": "Artificial intelligence"}}, {"uri": "http://en.wikipedia.org/wiki/Chennai", "type": "loc", "score": 2, "label": {"eng": "Chennai"}, "location": {"type": "place", "label": {"eng": "Chennai"}, "country": {"type": "country", "label": {"eng": "India"}}}}, {"uri": "http://en.wikipedia.org/wiki/Srinivasa_Ramanujan", "type": "person", "score": 1, "label": {"eng": "Srinivasa Ramanujan"}}, {"uri": "http://en.wikipedia.org/wiki/Productivity", "type": "wiki", "score": 1, "label": {"eng": "Productivity"}}, {"uri": "http://en.wikipedia.org/wiki/Information_technology", "type": "wiki", "score": 1, "label": {"eng": "Information technology"}}, {"uri": "http://en.wikipedia.org/wiki/Ecosystem", "type": "wiki", "score": 1, "label": {"eng": "Ecosystem"}}, {"uri": "http://en.wikipedia.org/wiki/Economic_development", "type": "wiki", "score": 1, "label": {"eng": "Economic development"}}, {"uri": "http://en.wikipedia.org/wiki/Pharmaceutical_industry", "type": "wiki", "score": 1, "label": {"eng": "Pharmaceutical industry"}}, {"uri": "http://en.wikipedia.org/wiki/Chief_executive_officer", "type": "wiki", "score": 1, "label": {"eng": "Chief executive officer"}}], "categories": [{"uri": "dmoz/Business", "label": "dmoz/Business", "wgt": 100}, {"uri": "dmoz/Business/Biotechnology_and_Pharmaceuticals", "label": "dmoz/Business/Biotechnology and Pharmaceuticals", "wgt": 100}, {"uri": "dmoz/Business/Biotechnology_and_Pharmaceuticals/Consulting", "label": "dmoz/Business/Biotechnology and Pharmaceuticals/Consulting", "wgt": 100}, {"uri": "news/Business", "label": "news/Business", "wgt": 96}], "image": "https://imgeng.jagran.com/images/2024/07/04/article/image/Astrazeneca-1720089476826.jpg", "originalArticle": null, "storyUri": "eng-9706315", "eventUri": "eng-9706315", "location": {"type": "country", "label": {"eng": "India"}}, "extractedDates": [{"amb": false, "imp": true, "date": "2024-07-24", "textStart": 849, "textEnd": 858}], "sentiment": 0.4823529411764707, "wgt": 232, "relevance": 1}
{"uri": "8209540038", "lang": "eng", "isDuplicate": false, "date": "2024-07-04", "time": "12:32:50", "dateTime": "2024-07-04T12:32:50Z", "dateTimePub": "2024-07-04T12:32:16Z", "dataType": "news", "sim": 0.8941176533699036, "url": "https://www.dtnext.in/news/business/astrazeneca-to-invest-rs-250-cr-in-chennai-to-expand-its-global-innovation-and-tech-centre-793264", "title": "AstraZeneca to invest Rs 250 cr in Chennai to expand its global innovation and tech centre", "body": "CHENNAI: AstraZeneca India Private Limited (AZIPL), the Global Capability Centre (GCC) of AstraZeneca, announced an investment of Rs 250 cr ($30 million) to expand its Global Innovation and Technology Centre (GITC) in Chennai, which includes close to 1,300 roles focused on driving innovation, enhancing efficiency, and streamlining operations across the company globally.\n\nThe expanded facility was inaugurated on Thursday in a ceremony officiated by the TN industries minister TRB Rajaa, British Deputy High Commissioner to India Christina Scott CMG, AstraZeneca VP for Asia Area Sylvia Varela, as well as AstraZeneca's leadership team in the country, as per a release.\n\nThe investment marks a significant milestone in AstraZeneca's growth story in India as it celebrates its 45th year in the country this month. With the highly skilled roles to be brought in by 2025, the expanded GITC will propel the company's vision to leverage technologies such as enterprise platforms, artificial intelligence, machine learning, data science, and supply chain analytics to shape healthcare outcomes.\n\nSiva Padmanabhan, MD, AZIPL, said: \"At AstraZeneca, we are evolving our technologies constantly so that we can stay ahead of the curve in healthcare and pharmaceutical industries to better serve our patients in countries where we operate. We are deeply invested in infusing the best of technology and innovation practices into the healthcare ecosystem.\"\n\nMK Stalin, chief minister, said: \"Technology is the driving force behind innovation and we are committed to make TN an epicentre of technology and research. This collaboration with AstraZeneca aligns perfectly with our vision to foster innovation and create high-value opportunities for the people of Tamil Nadu. We are committed to ensure TN's position as a premier investment destination for companies around the world.\"\n\nRaaja said \"AstraZeneca's decision to further expand their facility in Chennai is a reinforcement of their faith and commitment to TN's unmatched talent pool and business ecosystem. In the last three years, Chennai has rapidly emerged as the GCC capital of India, leading to historical levels of office space absorption and bringing high-quality jobs to the state. We are delighted that AstraZeneca is part of this exciting growth journey. This investment will not only enhance our state's capabilities in the pharmaceutical and healthcare sectors but also spur technological advancements and economic development. With this expansion and talent exposure, AstraZeneca is contributing to our vision of making TN a global hub for innovation-driven industries.\"\n\nSince its inception, the GITC in Chennai has evolved from providing traditional IT services to becoming an engine of AstraZeneca's digital journey, driving productivity, simplification, technology delivery, and innovation across the company's global operations, supporting the delivery of life-changing medicines to patients worldwide.\n\nThe facility currently occupies 334,000 square feet of office space at Ramanujan IT City, with plans to add approximately 180,000 square feet over the next six months to accommodate this expansion, creating AstraZeneca's biggest GCC.\n\nAstraZeneca has a strong hub for technology as well as R&D in India. Including the GITC, it employs over 4,000 in the country.", "source": {"uri": "dtnext.in", "dataType": "news", "title": "dtNext.in"}, "authors": [], "concepts": [{"uri": "http://en.wikipedia.org/wiki/AstraZeneca", "type": "org", "score": 5, "label": {"eng": "AstraZeneca"}}, {"uri": "http://en.wikipedia.org/wiki/Health_care", "type": "wiki", "score": 5, "label": {"eng": "Health care"}}, {"uri": "http://en.wikipedia.org/wiki/Tennessee", "type": "loc", "score": 5, "label": {"eng": "Tennessee"}, "location": {"type": "place", "label": {"eng": "Tennessee"}, "country": {"type": "country", "label": {"eng": "United States"}}}}, {"uri": "http://en.wikipedia.org/wiki/Chennai", "type": "loc", "score": 5, "label": {"eng": "Chennai"}, "location": {"type": "place", "label": {"eng": "Chennai"}, "country": {"type": "country", "label": {"eng": "India"}}}}, {"uri": "http://en.wikipedia.org/wiki/India", "type": "loc", "score": 5, "label": {"eng": "India"}, "location": {"type": "country", "label": {"eng": "India"}}}, {"uri": "http://en.wikipedia.org/wiki/Gulf_Cooperation_Council", "type": "org", "score": 3, "label": {"eng": "Gulf Cooperation Council"}}, {"uri": "http://en.wikipedia.org/wiki/Order_of_St_Michael_and_St_George", "type": "wiki", "score": 3, "label": {"eng": "Order of St Michael and St George"}}, {"uri": "http://en.wikipedia.org/wiki/Privately_held_company", "type": "wiki", "score": 3, "label": {"eng": "Privately held company"}}, {"uri": "http://en.wikipedia.org/wiki/Vice_president", "type": "wiki", "score": 3, "label": {"eng": "Vice president"}}, {"uri": "http://en.wikipedia.org/wiki/Indian_rupee", "type": "wiki", "score": 3, "label": {"eng": "Indian rupee"}}, {"uri": "http://en.wikipedia.org/wiki/Asia", "type": "loc", "score": 3, "label": {"eng": "Asia"}, "location": null}, {"uri": "http://en.wikipedia.org/wiki/United_Kingdom", "type": "loc", "score": 3, "label": {"eng": "United Kingdom"}, "location": {"type": "country", "label": {"eng": "United Kingdom"}}}, {"uri": "http://en.wikipedia.org/wiki/Chief_minister", "type": "wiki", "score": 2, "label": {"eng": "Chief minister"}}, {"uri": "http://en.wikipedia.org/wiki/M._K._Stalin", "type": "person", "score": 2, "label": {"eng": "M. K. Stalin"}}, {"uri": "http://en.wikipedia.org/wiki/Supply_chain", "type": "wiki", "score": 2, "label": {"eng": "Supply chain"}}, {"uri": "http://en.wikipedia.org/wiki/Machine_learning", "type": "wiki", "score": 2, "label": {"eng": "Machine learning"}}, {"uri": "http://en.wikipedia.org/wiki/Analytics", "type": "wiki", "score": 2, "label": {"eng": "Analytics"}}, {"uri": "http://en.wikipedia.org/wiki/Data_science", "type": "wiki", "score": 2, "label": {"eng": "Data science"}}, {"uri": "http://en.wikipedia.org/wiki/Ecosystem", "type": "wiki", "score": 2, "label": {"eng": "Ecosystem"}}, {"uri": "http://en.wikipedia.org/wiki/Artificial_intelligence", "type": "wiki", "score": 2, "label": {"eng": "Artificial intelligence"}}, {"uri": "http://en.wikipedia.org/wiki/Pharmaceutical_industry", "type": "wiki", "score": 2, "label": {"eng": "Pharmaceutical industry"}}, {"uri": "http://en.wikipedia.org/wiki/Chief_executive_officer", "type": "wiki", "score": 2, "label": {"eng": "Chief executive officer"}}, {"uri": "http://en.wikipedia.org/wiki/Tamil_Nadu", "type": "loc", "score": 2, "label": {"eng": "Tamil Nadu"}, "location": {"type": "place", "label": {"eng": "Tamil Nadu"}, "country": {"type": "country", "label": {"eng": "India"}}}}, {"uri": "http://en.wikipedia.org/wiki/Medication", "type": "wiki", "score": 1, "label": {"eng": "Medication"}}, {"uri": "http://en.wikipedia.org/wiki/Srinivasa_Ramanujan", "type": "person", "score": 1, "label": {"eng": "Srinivasa Ramanujan"}}, {"uri": "http://en.wikipedia.org/wiki/Global_city", "type": "wiki", "score": 1, "label": {"eng": "Global city"}}, {"uri": "http://en.wikipedia.org/wiki/Productivity", "type": "wiki", "score": 1, "label": {"eng": "Productivity"}}, {"uri": "http://en.wikipedia.org/wiki/Information_technology", "type": "wiki", "score": 1, "label": {"eng": "Information technology"}}, {"uri": "http://en.wikipedia.org/wiki/Economic_development", "type": "wiki", "score": 1, "label": {"eng": "Economic development"}}, {"uri": "http://en.wikipedia.org/wiki/Research_and_development", "type": "wiki", "score": 1, "label": {"eng": "Research and development"}}], "categories": [{"uri": "dmoz/Business", "label": "dmoz/Business", "wgt": 100}, {"uri": "dmoz/Business/Biotechnology_and_Pharmaceuticals", "label": "dmoz/Business/Biotechnology and Pharmaceuticals", "wgt": 100}, {"uri": "dmoz/Business/Opportunities/Inventions", "label": "dmoz/Business/Opportunities/Inventions", "wgt": 100}, {"uri": "dmoz/Business/Textiles_and_Nonwovens/Consulting", "label": "dmoz/Business/Textiles and Nonwovens/Consulting", "wgt": 100}, {"uri": "news/Business", "label": "news/Business", "wgt": 86}], "image": "https://dtnext-prod.s3.ap-south-1.amazonaws.com/h-upload/2024/07/04/832388-untitled1.webp", "originalArticle": null, "storyUri": "eng-9706315", "eventUri": "eng-9706315", "location": {"type": "place", "label": {"eng": "Chennai"}, "country": {"type": "country", "label": {"eng": "India"}}}, "extractedDates": null, "sentiment": 0.5372549019607844, "wgt": 228, "relevance": 1}
{"uri": "8209312120", "lang": "eng", "isDuplicate": false, "date": "2024-07-04", "time": "10:08:39", "dateTime": "2024-07-04T10:08:39Z", "dateTimePub": "2024-07-04T10:08:18Z", "dataType": "news", "sim": 0.8235294222831726, "url": "https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/astrazeneca-to-invest-rs-250-crore-on-expansion-of-its-gcc-in-india/articleshow/111485795.cms", "title": "AstraZeneca to invest Rs 250 crore on expansion of its GCC in India", "body": "AstraZeneca India Private Limited (AZIPL), the global capability centre (GCC) of British-Swedish drugmaker AstraZeneca, announced an investment of Rs 250 crore ($30 million) to expand its Global Innovation and Technology Centre (GITC) in Chennai.\n\nThe expansion includes adding close to 1,300 job roles focused on driving innovation, enhancing efficiency, and streamlining operations across the company globally.\n\nThe facility currently occupies 334,000 square feet of office space at Ramanujan IT City, with plans to add approximately 180,000 square feet over the next six months to accommodate this expansion, creating AstraZeneca's biggest global capability centre.\n\nThe expanded GITC will leverage technologies such as enterprise platforms, artificial intelligence, machine learning, data science, and supply chain analytics to shape healthcare outcomes.\n\nSince its inception, the GITC in Chennai has evolved from providing traditional information technology support services to becoming an engine of AstraZeneca's digital journey, driving productivity, simplification, technology delivery, and innovation across the company's global operations, supporting the delivery of life-changing medicines to patients worldwide.\n\nIncluding GITC, AstraZeneca employs more than 4000 people in the country and is continuously shaping talent that is skilled, diverse and future ready.\n\nApart from being a hub for technology as well as research and development, AstraZeneca markets and distributes its innovative portfolio in specialist disease areas including oncology, cardio-vascular, respiratory and rare disease.\n\nThe investment marks AstraZeneca's 45th year in India.\n\n\"Our expansion in Chennai signifies AstraZeneca's unwavering commitment to pioneering science and innovation,\" said Dr. Sanjeev Panchal, managing director & country president AstraZeneca Pharma India.\n\n\"This strategic investment underscores our dedication to improving patient outcomes through cutting-edge technology and reinforces our aspiration to transform the future of the healthcare industry,\" Panchal added.", "source": {"uri": "economictimes.indiatimes.com", "dataType": "news", "title": "Economic Times"}, "authors": [], "concepts": [{"uri": "http://en.wikipedia.org/wiki/AstraZeneca", "type": "org", "score": 5, "label": {"eng": "AstraZeneca"}}, {"uri": "http://en.wikipedia.org/wiki/Chennai", "type": "loc", "score": 4, "label": {"eng": "Chennai"}, "location": {"type": "place", "label": {"eng": "Chennai"}, "country": {"type": "country", "label": {"eng": "India"}}}}, {"uri": "http://en.wikipedia.org/wiki/Gulf_Cooperation_Council", "type": "org", "score": 3, "label": {"eng": "Gulf Cooperation Council"}}, {"uri": "http://en.wikipedia.org/wiki/Privately_held_company", "type": "wiki", "score": 3, "label": {"eng": "Privately held company"}}, {"uri": "http://en.wikipedia.org/wiki/Indian_rupee", "type": "wiki", "score": 3, "label": {"eng": "Indian rupee"}}, {"uri": "http://en.wikipedia.org/wiki/Crore", "type": "wiki", "score": 3, "label": {"eng": "Crore"}}, {"uri": "http://en.wikipedia.org/wiki/Information_technology", "type": "wiki", "score": 3, "label": {"eng": "Information technology"}}, {"uri": "http://en.wikipedia.org/wiki/India", "type": "loc", "score": 3, "label": {"eng": "India"}, "location": {"type": "country", "label": {"eng": "India"}}}, {"uri": "http://en.wikipedia.org/wiki/Supply_chain", "type": "wiki", "score": 2, "label": {"eng": "Supply chain"}}, {"uri": "http://en.wikipedia.org/wiki/Productivity", "type": "wiki", "score": 2, "label": {"eng": "Productivity"}}, {"uri": "http://en.wikipedia.org/wiki/Machine_learning", "type": "wiki", "score": 2, "label": {"eng": "Machine learning"}}, {"uri": "http://en.wikipedia.org/wiki/Analytics", "type": "wiki", "score": 2, "label": {"eng": "Analytics"}}, {"uri": "http://en.wikipedia.org/wiki/Data_science", "type": "wiki", "score": 2, "label": {"eng": "Data science"}}, {"uri": "http://en.wikipedia.org/wiki/Artificial_intelligence", "type": "wiki", "score": 2, "label": {"eng": "Artificial intelligence"}}, {"uri": "http://en.wikipedia.org/wiki/Health_care", "type": "wiki", "score": 2, "label": {"eng": "Health care"}}, {"uri": "http://en.wikipedia.org/wiki/Healthcare_industry", "type": "wiki", "score": 1, "label": {"eng": "Healthcare industry"}}, {"uri": "http://en.wikipedia.org/wiki/Oncology", "type": "wiki", "score": 1, "label": {"eng": "Oncology"}}, {"uri": "http://en.wikipedia.org/wiki/Research_and_development", "type": "wiki", "score": 1, "label": {"eng": "Research and development"}}, {"uri": "http://en.wikipedia.org/wiki/Chief_executive_officer", "type": "wiki", "score": 1, "label": {"eng": "Chief executive officer"}}, {"uri": "http://en.wikipedia.org/wiki/Respiratory_system", "type": "wiki", "score": 1, "label": {"eng": "Respiratory system"}}], "categories": [{"uri": "dmoz/Business/Biotechnology_and_Pharmaceuticals", "label": "dmoz/Business/Biotechnology and Pharmaceuticals", "wgt": 100}, {"uri": "dmoz/Business/Healthcare/Marketing_and_Advertising", "label": "dmoz/Business/Healthcare/Marketing and Advertising", "wgt": 100}, {"uri": "dmoz/Business/Opportunities/Inventions", "label": "dmoz/Business/Opportunities/Inventions", "wgt": 100}, {"uri": "dmoz/Business/Biotechnology_and_Pharmaceuticals/Consulting", "label": "dmoz/Business/Biotechnology and Pharmaceuticals/Consulting", "wgt": 100}, {"uri": "news/Business", "label": "news/Business", "wgt": 72}], "image": "https://img.etimg.com/thumb/msid-111485778,width-1200,height-630,imgsize-12014,overlay-economictimes/photo.jpg", "originalArticle": null, "storyUri": "eng-9706315", "eventUri": "eng-9706315", "location": {"type": "country", "label": {"eng": "India"}}, "extractedDates": null, "sentiment": 0.584313725490196, "wgt": 210, "relevance": 1}
{"uri": "8209255594", "lang": "eng", "isDuplicate": false, "date": "2024-07-04", "time": "09:34:09", "dateTime": "2024-07-04T09:34:09Z", "dateTimePub": "2024-07-04T09:33:51Z", "dataType": "news", "sim": 0.7607843279838562, "url": "https://www.thehindubusinessline.com/news/astrazeneca-to-invest-250-cr-in-chennai/article68366243.ece", "title": "AstraZeneca to invest \u20b9250 cr in Chennai", "body": "AstraZeneca India Private Limited (AZIPL), the global capability centre (GCC) of AstraZeneca, will invest \u20b9250 crore ($30 million) to expand its global innovation and technology centre (GITC) in Chennai, Tamil Nadu. This includes around 1,300 roles focused on driving innovation, enhancing efficiency, and streamlining operations across the company globally, according to a media release.\n\nThe inauguration of the expanded facility on Thursday was officiated by TN Minister of Industries TRB Rajaa, British Deputy High Commissioner to India Christina Scott CMG, and AstraZeneca's Vice President for Asia Area Sylvia Varela.\n\nThe investment comes as the company marks its 45th year in the country this month. With the expanded GITC and workforce by 2025, the company aims to leverage technologies such as enterprise platforms, artificial intelligence, machine learning, data science, and supply chain analytics.\n\nSiva Padmanabhan, Managing Director, AZIPL, said: \"We are evolving our technologies constantly so that we can stay ahead of the curve in healthcare and pharmaceutical industries to better serve our patients in countries where we operate. We are deeply invested in infusing the best of technology and innovation practices into the healthcare ecosystem.\"\n\nRajaa said Chennai has rapidly emerged as the GCC capital of India, leading to historical levels of office space absorption and bringing high-quality jobs to the state.\n\nAlso read\n\nPharmexcil moots more India-Russia pharma ties for self-reliance\n\nAstraZeneca's Imfinzi plus chemotherapy gets USFDA nod for certain type of endometrial cancer\n\nAstraZeneca to build $1.5 billion manufacturing facility in Singapore\n\nThe company's 3.34 lakh sq ft office space at Ramanujan IT City will expand by about 1.8 lakh sq ft over the next six months to become its biggest GCC. Together with the GITC, it employs more than 4,000 in the country, the release said.\n\nSHARE Copy linkEmailFacebookTwitterTelegramLinkedInWhatsAppRedditPublished on July 4, 2024", "source": {"uri": "thehindubusinessline.com", "dataType": "news", "title": "@businessline"}, "authors": [], "concepts": [{"uri": "http://en.wikipedia.org/wiki/AstraZeneca", "type": "org", "score": 5, "label": {"eng": "AstraZeneca"}}, {"uri": "http://en.wikipedia.org/wiki/India", "type": "loc", "score": 5, "label": {"eng": "India"}, "location": {"type": "country", "label": {"eng": "India"}}}, {"uri": "http://en.wikipedia.org/wiki/Gulf_Cooperation_Council", "type": "org", "score": 3, "label": {"eng": "Gulf Cooperation Council"}}, {"uri": "http://en.wikipedia.org/wiki/Privately_held_company", "type": "wiki", "score": 3, "label": {"eng": "Privately held company"}}, {"uri": "http://en.wikipedia.org/wiki/Indian_rupee", "type": "wiki", "score": 3, "label": {"eng": "Indian rupee"}}, {"uri": "http://en.wikipedia.org/wiki/Crore", "type": "wiki", "score": 3, "label": {"eng": "Crore"}}, {"uri": "http://en.wikipedia.org/wiki/Tennessee", "type": "loc", "score": 3, "label": {"eng": "Tennessee"}, "location": {"type": "place", "label": {"eng": "Tennessee"}, "country": {"type": "country", "label": {"eng": "United States"}}}}, {"uri": "http://en.wikipedia.org/wiki/Chennai", "type": "loc", "score": 3, "label": {"eng": "Chennai"}, "location": {"type": "place", "label": {"eng": "Chennai"}, "country": {"type": "country", "label": {"eng": "India"}}}}, {"uri": "http://en.wikipedia.org/wiki/United_Kingdom", "type": "loc", "score": 3, "label": {"eng": "United Kingdom"}, "location": {"type": "country", "label": {"eng": "United Kingdom"}}}, {"uri": "http://en.wikipedia.org/wiki/Order_of_St_Michael_and_St_George", "type": "wiki", "score": 2, "label": {"eng": "Order of St Michael and St George"}}, {"uri": "http://en.wikipedia.org/wiki/Supply_chain", "type": "wiki", "score": 2, "label": {"eng": "Supply chain"}}, {"uri": "http://en.wikipedia.org/wiki/Machine_learning", "type": "wiki", "score": 2, "label": {"eng": "Machine learning"}}, {"uri": "http://en.wikipedia.org/wiki/Analytics", "type": "wiki", "score": 2, "label": {"eng": "Analytics"}}, {"uri": "http://en.wikipedia.org/wiki/Data_science", "type": "wiki", "score": 2, "label": {"eng": "Data science"}}, {"uri": "http://en.wikipedia.org/wiki/Vice_President_of_the_United_States", "type": "wiki", "score": 2, "label": {"eng": "Vice President of the United States"}}, {"uri": "http://en.wikipedia.org/wiki/Artificial_intelligence", "type": "wiki", "score": 2, "label": {"eng": "Artificial intelligence"}}, {"uri": "http://en.wikipedia.org/wiki/Health_care", "type": "wiki", "score": 2, "label": {"eng": "Health care"}}, {"uri": "http://en.wikipedia.org/wiki/Pharmaceutical_industry", "type": "wiki", "score": 2, "label": {"eng": "Pharmaceutical industry"}}, {"uri": "http://en.wikipedia.org/wiki/Asia", "type": "loc", "score": 2, "label": {"eng": "Asia"}, "location": null}, {"uri": "http://en.wikipedia.org/wiki/Chief_executive_officer", "type": "wiki", "score": 2, "label": {"eng": "Chief executive officer"}}, {"uri": "http://en.wikipedia.org/wiki/Ramanujan_IT_City", "type": "wiki", "score": 1, "label": {"eng": "Ramanujan IT City"}}, {"uri": "http://en.wikipedia.org/wiki/Endometrial_cancer", "type": "wiki", "score": 1, "label": {"eng": "Endometrial cancer"}}, {"uri": "http://en.wikipedia.org/wiki/Individualism", "type": "wiki", "score": 1, "label": {"eng": "Individualism"}}, {"uri": "http://en.wikipedia.org/wiki/Food_and_Drug_Administration", "type": "wiki", "score": 1, "label": {"eng": "Food and Drug Administration"}}, {"uri": "http://en.wikipedia.org/wiki/Lakh", "type": "wiki", "score": 1, "label": {"eng": "Lakh"}}, {"uri": "http://en.wikipedia.org/wiki/Ecosystem", "type": "wiki", "score": 1, "label": {"eng": "Ecosystem"}}, {"uri": "http://en.wikipedia.org/wiki/Chemotherapy", "type": "wiki", "score": 1, "label": {"eng": "Chemotherapy"}}, {"uri": "http://en.wikipedia.org/wiki/Singapore", "type": "loc", "score": 1, "label": {"eng": "Singapore"}, "location": {"type": "country", "label": {"eng": "Singapore"}}}], "categories": [{"uri": "dmoz/Business", "label": "dmoz/Business", "wgt": 100}, {"uri": "dmoz/Business/Major_Companies", "label": "dmoz/Business/Major Companies", "wgt": 100}, {"uri": "dmoz/Business/Biotechnology_and_Pharmaceuticals/Consulting", "label": "dmoz/Business/Biotechnology and Pharmaceuticals/Consulting", "wgt": 100}, {"uri": "dmoz/Business/Information_Technology/Marketing_and_Advertising", "label": "dmoz/Business/Information Technology/Marketing and Advertising", "wgt": 100}, {"uri": "news/Business", "label": "news/Business", "wgt": 85}], "image": "https://bl-i.thgim.com/public/incoming/dl6q7h/article68366330.ece/alternates/LANDSCAPE_1200/2023-11-14T071416Z_1086648159_RC2UC4AMCQ7B_RTRMADP_3_ASTRAZENECA-IMFINZI-TRIAL.JPG", "originalArticle": null, "storyUri": "eng-9706315", "eventUri": "eng-9706315", "location": {"type": "country", "label": {"eng": "India"}}, "extractedDates": null, "sentiment": 0.3254901960784313, "wgt": 194, "relevance": 1}
{"uri": "8209741805", "lang": "eng", "isDuplicate": false, "date": "2024-07-04", "time": "14:50:51", "dateTime": "2024-07-04T14:50:51Z", "dateTimePub": "2024-07-04T14:50:31Z", "dataType": "news", "sim": 0.7568627595901489, "url": "https://www.thehindu.com/news/national/tamil-nadu/astrazeneca-to-invest-250-crore-to-expand-its-global-innovation-and-technology-centre-in-chennai/article68367148.ece", "title": "AstraZeneca to invest \u20b9250 crore to expand its global innovation and technology centre in Chennai", "body": "AstraZeneca India Private Limited (AZIPL), the Global Capability Centre (GCC) of the company, has announced an investment of \u20b9250 crore ($30 million) to expand its Global Innovation and Technology Centre (GITC) in Chennai, which includes close to 1,300 roles focused on driving innovation, enhancing efficiency, and streamlining operations across the company globally.\n\nThe company in a statement said: \"With the highly skilled roles to be brought in by 2025, the expanded GITC will propel company's vision to leverage technologies such as enterprise platforms, artificial intelligence, machine learning, data science, and supply chain analytics to shape healthcare outcomes.\"\n\nSiva Padmanabhan, managing director, AstraZeneca India Private Limited, said: \"At AstraZeneca, we are evolving our technologies constantly so that we can stay ahead of the curve in healthcare and pharmaceutical industries to better serve our patients in countries where we operate.\"\n\nTamil Nadu's Industries Minister T.R.B.Rajaa, said: \"This investment will not only enhance our State's capabilities in the pharmaceutical and healthcare sectors but also spur technological advancements and economic development.\"\n\nThe facility currently occupies 3,34,000 sq.ft. office space at Ramanujan IT City, with plans to add approximately 1,80,000 sq.ft. over the next six months to accommodate this expansion, creating AstraZeneca's biggest global capability centre.\n\nRead Comments", "source": {"uri": "thehindu.com", "dataType": "news", "title": "The Hindu"}, "authors": [], "concepts": [{"uri": "http://en.wikipedia.org/wiki/AstraZeneca", "type": "org", "score": 4, "label": {"eng": "AstraZeneca"}}, {"uri": "http://en.wikipedia.org/wiki/Privately_held_company", "type": "wiki", "score": 4, "label": {"eng": "Privately held company"}}, {"uri": "http://en.wikipedia.org/wiki/India", "type": "loc", "score": 4, "label": {"eng": "India"}, "location": {"type": "country", "label": {"eng": "India"}}}, {"uri": "http://en.wikipedia.org/wiki/Gulf_Cooperation_Council", "type": "org", "score": 3, "label": {"eng": "Gulf Cooperation Council"}}, {"uri": "http://en.wikipedia.org/wiki/Indian_rupee", "type": "wiki", "score": 3, "label": {"eng": "Indian rupee"}}, {"uri": "http://en.wikipedia.org/wiki/Crore", "type": "wiki", "score": 3, "label": {"eng": "Crore"}}, {"uri": "http://en.wikipedia.org/wiki/Health_care", "type": "wiki", "score": 3, "label": {"eng": "Health care"}}, {"uri": "http://en.wikipedia.org/wiki/Chennai", "type": "loc", "score": 3, "label": {"eng": "Chennai"}, "location": {"type": "place", "label": {"eng": "Chennai"}, "country": {"type": "country", "label": {"eng": "India"}}}}, {"uri": "http://en.wikipedia.org/wiki/Supply_chain", "type": "wiki", "score": 2, "label": {"eng": "Supply chain"}}, {"uri": "http://en.wikipedia.org/wiki/Machine_learning", "type": "wiki", "score": 2, "label": {"eng": "Machine learning"}}, {"uri": "http://en.wikipedia.org/wiki/Analytics", "type": "wiki", "score": 2, "label": {"eng": "Analytics"}}, {"uri": "http://en.wikipedia.org/wiki/Data_science", "type": "wiki", "score": 2, "label": {"eng": "Data science"}}, {"uri": "http://en.wikipedia.org/wiki/Artificial_intelligence", "type": "wiki", "score": 2, "label": {"eng": "Artificial intelligence"}}, {"uri": "http://en.wikipedia.org/wiki/Pharmaceutical_industry", "type": "wiki", "score": 2, "label": {"eng": "Pharmaceutical industry"}}, {"uri": "http://en.wikipedia.org/wiki/Chief_executive_officer", "type": "wiki", "score": 2, "label": {"eng": "Chief executive officer"}}, {"uri": "http://en.wikipedia.org/wiki/Ramanujan_IT_City", "type": "wiki", "score": 1, "label": {"eng": "Ramanujan IT City"}}, {"uri": "http://en.wikipedia.org/wiki/Tamil_Nadu", "type": "loc", "score": 1, "label": {"eng": "Tamil Nadu"}, "location": {"type": "place", "label": {"eng": "Tamil Nadu"}, "country": {"type": "country", "label": {"eng": "India"}}}}], "categories": [{"uri": "dmoz/Business", "label": "dmoz/Business", "wgt": 100}, {"uri": "dmoz/Business/Financial_Services/Venture_Capital", "label": "dmoz/Business/Financial Services/Venture Capital", "wgt": 100}, {"uri": "dmoz/Business/Biotechnology_and_Pharmaceuticals/Consulting", "label": "dmoz/Business/Biotechnology and Pharmaceuticals/Consulting", "wgt": 100}, {"uri": "dmoz/Business/Information_Technology/Marketing_and_Advertising", "label": "dmoz/Business/Information Technology/Marketing and Advertising", "wgt": 100}, {"uri": "news/Business", "label": "news/Business", "wgt": 83}], "image": "https://th-i.thgim.com/public/news/national/tamil-nadu/azoz8q/article68367557.ece/alternates/LANDSCAPE_1200/63ee68aa-e7b7-4935-9757-4f9b31f5ec6c.jfif", "originalArticle": null, "storyUri": "eng-9706315", "eventUri": "eng-9706315", "location": {"type": "country", "label": {"eng": "India"}}, "extractedDates": null, "sentiment": 0.2549019607843137, "wgt": 193, "relevance": 1}
{"uri": "8209529378", "lang": "eng", "isDuplicate": false, "date": "2024-07-04", "time": "12:25:54", "dateTime": "2024-07-04T12:25:54Z", "dateTimePub": "2024-07-04T12:25:22Z", "dataType": "news", "sim": 0.7490196228027344, "url": "https://www.moneycontrol.com/news/business/astrazeneca-to-invest-rs-250-crore-for-gcc-expansion-in-chennai-12762421.html", "title": "AstraZeneca to invest Rs 250 crore for GCC expansion in Chennai", "body": "\"The strategic expansion includes creating close to 1,300 roles focused on driving innovation, enhancing efficiency, and streamlining operations globally,\" the company stated.\n\nAstraZeneca India Private Limited (AZIPL), the Global Capability Centre (GCC) of the pharmaceutical group AstraZeneca, on July 4 said it will invest Rs 250 crore ($30 million) in Chennai.\n\n\"The investment is to expand our Global Innovation and Technology Centre (GITC) in Chennai. This strategic expansion includes creating close to 1,300 roles focused on driving innovation, enhancing efficiency, and streamlining operations globally,\" the company stated.\n\nTamil Nadu Industries Minister TRB Rajaa said, \"We are thrilled to see AstraZeneca expanding their existing capacity with talent sourced from the huge talent pool available in TN. Their decision to reinvest and grow in Tamil Nadu is a powerful endorsement of our state - our people, our talent, and our policies.\"\n\n\"The rapid absorption of office spaces in Chennai underscores Tamil Nadu's position as the Knowledge Capital of India,\" he added.", "source": {"uri": "moneycontrol.com", "dataType": "news", "title": "MoneyControl"}, "authors": [], "concepts": [{"uri": "http://en.wikipedia.org/wiki/AstraZeneca", "type": "org", "score": 4, "label": {"eng": "AstraZeneca"}}, {"uri": "http://en.wikipedia.org/wiki/Gulf_Cooperation_Council", "type": "org", "score": 3, "label": {"eng": "Gulf Cooperation Council"}}, {"uri": "http://en.wikipedia.org/wiki/Chennai", "type": "loc", "score": 3, "label": {"eng": "Chennai"}, "location": {"type": "place", "label": {"eng": "Chennai"}, "country": {"type": "country", "label": {"eng": "India"}}}}, {"uri": "http://en.wikipedia.org/wiki/Indian_rupee", "type": "wiki", "score": 2, "label": {"eng": "Indian rupee"}}, {"uri": "http://en.wikipedia.org/wiki/Crore", "type": "wiki", "score": 2, "label": {"eng": "Crore"}}, {"uri": "http://en.wikipedia.org/wiki/Tamil_Nadu", "type": "loc", "score": 2, "label": {"eng": "Tamil Nadu"}, "location": {"type": "place", "label": {"eng": "Tamil Nadu"}, "country": {"type": "country", "label": {"eng": "India"}}}}, {"uri": "http://en.wikipedia.org/wiki/India", "type": "loc", "score": 2, "label": {"eng": "India"}, "location": {"type": "country", "label": {"eng": "India"}}}], "categories": [{"uri": "dmoz/Business/Financial_Services/Venture_Capital", "label": "dmoz/Business/Financial Services/Venture Capital", "wgt": 100}, {"uri": "dmoz/Business/Investing/Socially_Responsible", "label": "dmoz/Business/Investing/Socially Responsible", "wgt": 100}, {"uri": "dmoz/Business/Agriculture_and_Forestry/Consulting", "label": "dmoz/Business/Agriculture and Forestry/Consulting", "wgt": 100}, {"uri": "news/Business", "label": "news/Business", "wgt": 77}], "image": "https://images.moneycontrol.com/static-mcnews/2024/07/20240704120435_trb.jpg", "originalArticle": null, "storyUri": "eng-9706315", "eventUri": "eng-9706315", "location": null, "extractedDates": [{"amb": false, "imp": true, "date": "2024-07-04", "textStart": 299, "textEnd": 305}], "sentiment": 0.5294117647058822, "wgt": 191, "relevance": 1}
{"uri": "8209488412", "lang": "eng", "isDuplicate": false, "date": "2024-07-04", "time": "11:59:24", "dateTime": "2024-07-04T11:59:24Z", "dateTimePub": "2024-07-04T11:59:03Z", "dataType": "news", "sim": 0.7411764860153198, "url": "https://timesofindia.indiatimes.com/city/chennai/astrazeneca-expands-its-chennai-office-making-its-biggest-gcc-globally/articleshow/111489372.cms", "title": "AstraZeneca expands its Chennai office, making its biggest GCC globally | Chennai News - Times of India", "body": "CHENNAI: AstraZeneca India, the global capability centre (GCC) of British- Swedish pharmaceutical company AstraZeneca, on Thursday announced expansion of its campus in Chennai with an investment of Rs 250 crore.\n\nThe company plans to add 1.80 lakh sq ft over the next six months to accommodate 1,300 employees, making this facility -- called the Global Innovation and Technology Centre (GITC) -- its biggest global capability centre, according to a release from AstraZeneca.\n\nThe facility currently occupies 3.34 lakh square feet of office space in Ramanujan IT Park in Taramani.\n\nIt will focus on enterprise platforms, artificial intelligence, machine learning, data science and supply chain analytics for healthcare.\n\nSiva Padmanabhan, managing director of AstraZeneca India, said, \"At AstraZeneca, we are evolving our technologies constantly so that we can stay ahead of the curve in healthcare and pharmaceutical industries to better serve our patients in countries where we operate. We are deeply invested in infusing the best of technology and innovation practices into the healthcare ecosystem.\"\n\nThe GITC in Chennai initially started as a back office, providing traditional information technology service to play a crucial role in the company's technology delivery and innovation across the global operations. It supports the delivery of life-changing medicines to patients worldwide, the company said.\n\nThe expanded facility was inaugurated in a ceremony by state industries minister TRB Rajaa, British deputy high commissioner to India Christina Scott CMG, AstraZeneca vice-president for Asia Area Sylvia Varela and others.", "source": {"uri": "timesofindia.indiatimes.com", "dataType": "news", "title": "The Times of India"}, "authors": [{"uri": "vaitheeswaran_b@timesofindia.indiatimes.com", "name": "Vaitheeswaran B", "type": "author", "isAgency": false}], "concepts": [{"uri": "http://en.wikipedia.org/wiki/AstraZeneca", "type": "org", "score": 5, "label": {"eng": "AstraZeneca"}}, {"uri": "http://en.wikipedia.org/wiki/Chennai", "type": "loc", "score": 5, "label": {"eng": "Chennai"}, "location": {"type": "place", "label": {"eng": "Chennai"}, "country": {"type": "country", "label": {"eng": "India"}}}}, {"uri": "http://en.wikipedia.org/wiki/Lakh", "type": "wiki", "score": 4, "label": {"eng": "Lakh"}}, {"uri": "http://en.wikipedia.org/wiki/Pharmaceutical_industry", "type": "wiki", "score": 4, "label": {"eng": "Pharmaceutical industry"}}, {"uri": "http://en.wikipedia.org/wiki/India", "type": "loc", "score": 4, "label": {"eng": "India"}, "location": {"type": "country", "label": {"eng": "India"}}}, {"uri": "http://en.wikipedia.org/wiki/Gulf_Cooperation_Council", "type": "org", "score": 3, "label": {"eng": "Gulf Cooperation Council"}}, {"uri": "http://en.wikipedia.org/wiki/Indian_rupee", "type": "wiki", "score": 3, "label": {"eng": "Indian rupee"}}, {"uri": "http://en.wikipedia.org/wiki/Crore", "type": "wiki", "score": 3, "label": {"eng": "Crore"}}, {"uri": "http://en.wikipedia.org/wiki/Health_care", "type": "wiki", "score": 3, "label": {"eng": "Health care"}}, {"uri": "http://en.wikipedia.org/wiki/Sweden", "type": "loc", "score": 3, "label": {"eng": "Sweden"}, "location": {"type": "country", "label": {"eng": "Sweden"}}}, {"uri": "http://en.wikipedia.org/wiki/United_Kingdom", "type": "loc", "score": 3, "label": {"eng": "United Kingdom"}, "location": {"type": "country", "label": {"eng": "United Kingdom"}}}, {"uri": "http://en.wikipedia.org/wiki/Supply_chain", "type": "wiki", "score": 2, "label": {"eng": "Supply chain"}}, {"uri": "http://en.wikipedia.org/wiki/Machine_learning", "type": "wiki", "score": 2, "label": {"eng": "Machine learning"}}, {"uri": "http://en.wikipedia.org/wiki/Analytics", "type": "wiki", "score": 2, "label": {"eng": "Analytics"}}, {"uri": "http://en.wikipedia.org/wiki/Data_science", "type": "wiki", "score": 2, "label": {"eng": "Data science"}}, {"uri": "http://en.wikipedia.org/wiki/Information_technology", "type": "wiki", "score": 2, "label": {"eng": "Information technology"}}, {"uri": "http://en.wikipedia.org/wiki/Artificial_intelligence", "type": "wiki", "score": 2, "label": {"eng": "Artificial intelligence"}}, {"uri": "http://en.wikipedia.org/wiki/Chief_executive_officer", "type": "wiki", "score": 2, "label": {"eng": "Chief executive officer"}}, {"uri": "http://en.wikipedia.org/wiki/Order_of_St_Michael_and_St_George", "type": "wiki", "score": 1, "label": {"eng": "Order of St Michael and St George"}}, {"uri": "http://en.wikipedia.org/wiki/Back_office", "type": "wiki", "score": 1, "label": {"eng": "Back office"}}, {"uri": "http://en.wikipedia.org/wiki/Ecosystem", "type": "wiki", "score": 1, "label": {"eng": "Ecosystem"}}, {"uri": "http://en.wikipedia.org/wiki/Asia", "type": "loc", "score": 1, "label": {"eng": "Asia"}, "location": null}], "categories": [{"uri": "dmoz/Business", "label": "dmoz/Business", "wgt": 100}, {"uri": "dmoz/Business/Biotechnology_and_Pharmaceuticals", "label": "dmoz/Business/Biotechnology and Pharmaceuticals", "wgt": 100}, {"uri": "dmoz/Business/Employment/Recruitment_and_Staffing", "label": "dmoz/Business/Employment/Recruitment and Staffing", "wgt": 100}, {"uri": "dmoz/Business/Biotechnology_and_Pharmaceuticals/Consulting", "label": "dmoz/Business/Biotechnology and Pharmaceuticals/Consulting", "wgt": 100}, {"uri": "news/Business", "label": "news/Business", "wgt": 62}], "image": "https://static.toiimg.com/thumb/msid-111489326,width-1070,height-580,imgsize-1359387,resizemode-75,overlay-toi_sw,pt-32,y_pad-40/photo.jpg", "originalArticle": null, "storyUri": "eng-9706315", "eventUri": "eng-9706315", "location": {"type": "place", "label": {"eng": "Chennai"}, "country": {"type": "country", "label": {"eng": "India"}}}, "extractedDates": null, "sentiment": 0.3411764705882352, "wgt": 189, "relevance": 1}
{"uri": "8209515795", "lang": "eng", "isDuplicate": false, "date": "2024-07-04", "time": "12:16:20", "dateTime": "2024-07-04T12:16:20Z", "dateTimePub": "2024-07-04T12:16:02Z", "dataType": "news", "sim": 0.5764706134796143, "url": "https://www.business-standard.com/companies/news/astrazeneca-to-invest-rs-250-crore-in-expanding-its-gitc-in-chennai-124070400762_1.html", "title": "AstraZeneca to invest Rs 250 crore in expanding its GITC in Chennai", "body": "ALSO READ: AstraZeneca's Imfinzi fails in late-stage trial to treat lung cancer cases \"This new campus will be home to 4,000 high-quality jobs in Chennai, and we are thrilled to see AstraZeneca expanding their existing capacity with talent sourced from the huge talent pool available in Tamil Nadu! Their decision to reinvest and grow in Tamil Nadu is a powerful endorsement of our state -- our people, our talent, and our policies,\" said TRB Rajaa, state industries minister.", "source": {"uri": "business-standard.com", "dataType": "news", "title": "Business Standard"}, "authors": [], "concepts": [{"uri": "http://en.wikipedia.org/wiki/AstraZeneca", "type": "org", "score": 4, "label": {"eng": "AstraZeneca"}}, {"uri": "http://en.wikipedia.org/wiki/Lung", "type": "wiki", "score": 3, "label": {"eng": "Lung"}}, {"uri": "http://en.wikipedia.org/wiki/Cancer", "type": "wiki", "score": 3, "label": {"eng": "Cancer"}}, {"uri": "http://en.wikipedia.org/wiki/Chennai", "type": "loc", "score": 2, "label": {"eng": "Chennai"}, "location": {"type": "place", "label": {"eng": "Chennai"}, "country": {"type": "country", "label": {"eng": "India"}}}}, {"uri": "http://en.wikipedia.org/wiki/Tamil_Nadu", "type": "loc", "score": 2, "label": {"eng": "Tamil Nadu"}, "location": {"type": "place", "label": {"eng": "Tamil Nadu"}, "country": {"type": "country", "label": {"eng": "India"}}}}], "categories": [{"uri": "dmoz/Society/Issues", "label": "dmoz/Society/Issues", "wgt": 100}, {"uri": "dmoz/Society/Issues/Health", "label": "dmoz/Society/Issues/Health", "wgt": 100}, {"uri": "dmoz/Society/Religion_and_Spirituality/Sikhism", "label": "dmoz/Society/Religion and Spirituality/Sikhism", "wgt": 100}, {"uri": "dmoz/Society/Religion_and_Spirituality/Meditation", "label": "dmoz/Society/Religion and Spirituality/Meditation", "wgt": 100}], "image": "https://bsmedia.business-standard.com/_media/bs/img/article/2023-07/03/thumb/fitandfill/600X300/1688369760-8407.jpg", "originalArticle": null, "storyUri": "eng-9706315", "eventUri": "eng-9706315", "location": null, "extractedDates": null, "sentiment": 0.7333333333333334, "wgt": 147, "relevance": 1}
